Healthtech Platform Dozee Secures $6 Million Funding From SBI and Investors

0
579
Healthtech startup

Dozee intends to utilize the funds to onboard over 2,000 hospitals around the country during the following two years. The funds will be used to strengthen the startup’s R&D capabilities. Dozee has raised around $15.8 million in four fundraising rounds to far, including the most recent.

Dozee, a business that provides contactless remote patient monitoring and AI-based early warning systems, has secured $6 million in Series A2 investment. J&A Partners Family Office, Dinesh Mody Ventures, and State Bank of India were among the current and new investors who backed to the investment.

Dozee, located in Bengaluru, intends to utilize the funds to expand in the Indian market, seek worldwide markets, and invest in its R&D skills. The Contactless Vital Signs Measurement system, Dozee’s core product, just received 510(k) clearance from the US FDA, indicating that it fulfills global standards for medical devices and algorithms. Over the next two years, the business intends to connect into 2,000 hospitals in more than 100 regions.

Dozee is by now present in excess of 380 hospitals all over 50 districts. It recently teamed with British International Investment, a development finance organization and impact investor located in the United Kingdom, to link its technology to around 6,000 hospital beds in about 140 public hospitals all over India and other locales.

Dozee’s technology enables healthcare professionals to remotely monitor patients’ critical data and follow trends by making use of its early warning system, permitting for rapid medical intervention. It embeds sensors beneath the mattress to detect minuscule vibrations caused by every pulse, breathing cycle, tremor, seizure, and posture shift, all without making any touch.

Gaurav Parchani and Mudit Dandwate, both IIT graduates, created Dozee, a patient monitoring technology firm, in 2015. It claims to save more than 2.5 hours of nursing time per patient every day.

LEAVE A REPLY

Please enter your comment!
Please enter your name here